Medicare Enrolled

Dr. Kyle Fehlis, M.D.

Family Medicine · New Braunfels, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
457 LANDA ST STE C, New Braunfels, TX 78130
8306279088
In practice since 2009 (16 years)
NPI: 1215167119 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fehlis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fehlis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fehlis

Dr. Kyle Fehlis is a family medicine specialist in New Braunfels, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Fehlis performed 1,087 Medicare services across 638 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fehlis received a total of $8,589 from 45 pharmaceutical and/or device companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fehlis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 26% volume in TX $8,589 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,087
Medicare services
Top 26% in TX for family medicine
638
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~68 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
486 $75 $289
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
150 $1 $9
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
107 $60 $204
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
86 $126 $295
Betamethasone steroid injection
An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate.
64 $5 $20
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
57 $37 $127
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
38 $10 $89
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
25 $2 $7
Annual wellness visit, initial visit
A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment.
22 $162 $377
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
20 $37 $119
Transitional care management services, moderate complexity
Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity.
18 $154 $463
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
14 $10 $54
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,589
Total received (2018-2024)
Avg $1,227/year across 7 years
Top 6% in TX for family medicine
45
Companies
359
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,589 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$568
2023
$469
2022
$120
2021
$245
2020
$775
2019
$3,682
2018
$2,730

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$1,072
Amgen Inc.
$657
Amarin Pharma Inc.
$573
PFIZER INC.
$566
Novo Nordisk Inc
$363
AstraZeneca Pharmaceuticals LP
$359
Boehringer Ingelheim Pharmaceuticals, Inc.
$333
AbbVie, Inc.
$331
Teva Pharmaceuticals USA, Inc.
$323
Lilly USA, LLC
$302
SANOFI-AVENTIS U.S. LLC
$278
Takeda Pharmaceuticals U.S.A., Inc.
$269
Abbott Laboratories
$257
GlaxoSmithKline, LLC.
$246
Biosense Webster, Inc.
$240
Radius Health, Inc.
$222
Intuitive Surgical, Inc.
$207
Medtronic, Inc.
$180
Allergan Inc.
$178
AbbVie Inc.
$143
Shire North American Group Inc
$135
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$129
Nevro Corp.
$123
Biohaven Pharmaceuticals, Inc.
$117
Cardiovascular Systems Inc.
$104
Novartis Pharmaceuticals Corporation
$93
IDORSIA PHARMACEUTICALS US INC
$88
Genentech USA, Inc.
$86
Astellas Pharma US Inc
$72
Corium, LLC
$71
Otsuka America Pharmaceutical, Inc.
$68
Antares Pharma, Inc.
$58
Merck Sharp & Dohme LLC
$42
Sanofi Pasteur Inc.
$40
Allergan, Inc.
$38
Daiichi Sankyo Inc.
$35
Kowa Pharmaceuticals America, Inc.
$33
ABBVIE INC.
$28
ALK-Abello, Inc
$26
SANOFI PASTEUR INC.
$21
ARBOR PHARMACEUTICALS, INC.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Mylan Specialty L.P.
$19
E.R. Squibb & Sons, L.L.C.
$12
Noden Pharma USA Inc
$12
Top 3 companies account for 26.8% of total payments
Associated products mentioned in payments ›
AJOVY · ANORO · AZSTARYS · Aimovig · Amitiza · Androgel · BREO · BYDUREON · BYSTOLIC · CHANTIX · COLOGUARD · Carto 3 System · Carto Smarttouch · Da Vinci Surgical System · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FLUZONE HIGH-DOSE · FORTEO · Grastek · HeartMate · INVOKANA · JARDIANCE · KYPHON EXPRESS II KYPHOPAK TRAY · Kerendia · LINZESS · LOKELMA · LYRICA · Livalo · MAVYRET · MENACTRA · MYDAYIS · MYRBETRIQ · Mavyret · Motegrity · NO PRODUCT DISCUSSED · NURTEC ODT · Omnilink Elite vascular stent system · Otrexup · Ozempic · PROCLAIM · Prolia · QUVIVIQ · REXULTI · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SYNTHROID · Saxenda · Senza · Synthroid · TEKTURNA · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · VAXNEUVANCE · VENASEAL · VRAYLAR · VYVANSE · Vascepa · Victoza · Welchol · XARELTO · XIFAXAN · XIGDUO · XYOSTED · Xofluza · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for family medicine in TX.

Equivalent to $790 per 100 Medicare services performed
Looking for a family medicine specialist in New Braunfels?
Compare family medicine physicians in the New Braunfels area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
234
Per 100K population
131.2
County median income
$93,776
Nearest hospital
RESOLUTE HEALTH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Fehlis is a clinical cardiology specialist, with above-average Medicare volume (top 26% in TX), with low-engagement industry engagement in the top 6% of TX peers, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Fehlis experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Fehlis performed 486 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fehlis receive payments from pharmaceutical companies?
Yes. Dr. Fehlis received a total of $8,589 from 45 companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fehlis's costs compare to other family medicine physicians in New Braunfels?
Dr. Fehlis's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fehlis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →